Illumina cuts annual profit forecast for second straight quarter
(Reuters) – U.S. genetic testing Illumina on Thursday trimmed its annual profit forecast for the second straight quarter, hurt by weakness in demand for its …
illumina
Illumina wins fast-track appeal of FTC order to offload Grail
By Mike Scarcella (Reuters) – A U.S. appeals court on Tuesday said it will accelerate reviewing Illumina Inc’s challenge to a federal agency order requiring …
Ravgen settles patent fight with Illumina over genetic testing
By Blake Brittain (Reuters) – Gene-sequencing giant Illumina Inc has settled a patent lawsuit brought by Maryland biotech company Ravgen Inc, which accused Illumina’s genetic …
Carl Icahn prepares for proxy fight at Illumina – WSJ
(Reuters) – Activist investor Carl Icahn is preparing a proxy fight at Illumina Inc, arguing that the life science maker’s acquisition of Grail Inc cost …
Illumina cuts 5% of its workforce
(Reuters) – Illumina Inc said on Monday it was cutting 5% of its global workforce to realign its operating expenses as stubborn inflation and a …
Illumina wins case against U.S. FTC on Grail purchase – WSJ
(Reuters) – A judge has ruled in favor of Illumina Inc in its acquisition of Grail Inc dealing a blow to the U.S. Federal Trade …
Exclusive: EU antitrust regulators likely to block Illumina, Grail deal – sources
BRUSSELS – EU antitrust regulators are expected to veto U.S. life sciences firm Illumina’s acquisition of biotechnology company Grail, people familiar with the matter said …
Illumina loses challenge against EU antitrust probe into Grail deal
By Foo Yun Chee LUXEMBOURG -U.S. life sciences company Illumina on Wednesday lost its challenge against European Union scrutiny of its $8 billion cash-and-stock takeover …
EU court to rule July 13 on Illumina challenge of EU review of Grail -sources
By Foo Yun Chee BRUSSELS – A European court will decide on July 13 whether U.S. life sciences company Illumina’s $8 billion cash-and-stock takeover of …